Boehringer Ingelheim As COVID revenues disappoint, once-high-flying Pfizer looks at possible cost cuts
Boehringer Ingelheim Boehringer Ingelheim sees more Jardiance growth as potential US kidney disease approval nears
Boehringer Ingelheim TG taps Neuraxpharm to commercialize MS drug Briumvi overseas in deal worth up to $645M
Boehringer Ingelheim OSE Immunotherapeutics Announces New Public Grant to Support Innovation and Research Programs in the Field of RNA Therapeutics
Boehringer Ingelheim The Global Quantum Computing in Healthcare Market size is expected to reach $1 Billion by 2030, rising at a market growth of 45.4% CAGR during the forecast period
Boehringer Ingelheim Eli Lilly, Boehringer Ingelheim's Jardiance expands reach with key EU nod in chronic kidney disease
Boehringer Ingelheim American Indian and Alaska Native children experience high rates of RSV-related hospitalizations
Boehringer Ingelheim Respiratory patient groups see pharma's reputation as boosted in 2022, but decry pricing, access to lung meds
